Squarepoint Ops LLC Kala Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.3 - $1.31 $4,793 - $20,929	15,977 New	15,977 $5,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $287,549 - $463,148	-56,828 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.24 - $9.58 $68,964 - $105,878	11,052 Added 24.14%	56,828 $383,000
Q4 2020 Feb 16, 2021	SELL	$6.28 - $8.79 $247,928 - $347,020	-39,479 Reduced 46.31%	45,776 $310,000
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $776,692 - $1.15 Million	-103,559 Reduced 54.85%	85,255 $639,000
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $1.57 Million - $2.6 Million	188,814 New	188,814 $1.98 Million
Q1 2020 May 15, 2020	SELL	$3.83 - $8.79 $42,712 - $98,026	-11,152 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.36 - $4.81 $37,470 - $53,641	11,152 New	11,152 $41,000
Q3 2019 Nov 14, 2019	SELL	$3.57 - $6.58 $44,814 - $82,598	-12,553 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.93 - $8.8 $61,886 - $110,466	12,553 New	12,553 $80,000
Q1 2019 May 15, 2019	SELL	$5.19 - $8.97 $144,650 - $250,002	-27,871 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $13,174 - $30,525	3,071 Added 12.38%	27,871 $136,000
Q3 2018 Nov 14, 2018	BUY	$9.54 - $13.87 $236,591 - $343,976	24,800 New	24,800 $245,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $11.3M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.